Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 89.83
+5.61 (6.66%)
At close: Aug 17, 2026
Morepen Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 46,149 | 18,521 | 26,220 | 21,500 | 13,127 | 17,488 | |
Market Cap Growth | 81.47% | -29.36% | 21.95% | 63.79% | -24.94% | 20.93% |
Enterprise Value | 47,317 | 19,304 | 24,690 | 21,194 | 12,944 | 17,090 |
Last Close Price | 84.22 | 33.80 | 47.65 | 41.88 | 25.57 | 36.44 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.02 | 19.52 | 22.22 | 22.36 | 33.94 | 17.20 |
PS Ratio | 2.37 | 1.03 | 1.45 | 1.27 | 0.92 | 1.12 |
PB Ratio | 3.70 | 1.49 | 2.21 | 2.54 | 1.75 | 3.03 |
P/TBV Ratio | 4.09 | 1.64 | 2.60 | 2.86 | 2.01 | 3.69 |
P/FCF Ratio | - | - | - | 1078.33 | - | - |
P/OCF Ratio | 141.38 | 56.74 | 81.79 | 29.30 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.43 | 1.07 | 1.36 | 1.25 | 0.91 | 1.10 |
EV/EBITDA Ratio | 24.96 | 15.37 | 15.25 | 13.36 | 15.41 | 11.73 |
EV/EBIT Ratio | 31.92 | 21.64 | 17.02 | 16.93 | 23.08 | 14.48 |
EV/FCF Ratio | - | - | - | 1063.01 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.09 | 0.03 | 0.03 | 0.23 |
Debt / EBITDA Ratio | 1.10 | 1.65 | 0.60 | 0.18 | 0.30 | 0.91 |
Debt / FCF Ratio | - | - | - | 14.55 | - | - |
Net Debt / Equity Ratio | 0.09 | 0.09 | 0 | 0.01 | 0.01 | 0.20 |
Net Debt / EBITDA Ratio | 0.61 | 0.93 | 0.00 | 0.08 | 0.04 | 0.81 |
Net Debt / FCF Ratio | - | -2.20 | 0.00 | 6.05 | -0.03 | -1.11 |
Asset Turnover | - | 0.97 | 1.18 | 1.41 | 1.30 | 1.61 |
Inventory Turnover | - | 4.09 | 4.32 | 4.55 | 3.86 | 4.70 |
Quick Ratio | - | 0.87 | 0.86 | 0.87 | 0.90 | 0.59 |
Current Ratio | - | 2.37 | 2.32 | 2.21 | 2.35 | 1.61 |
Return on Equity (ROE) | - | 7.86% | 11.60% | 12.08% | 5.81% | 20.29% |
Return on Assets (ROA) | - | 3.00% | 5.91% | 6.51% | 3.21% | 7.65% |
Return on Invested Capital (ROIC) | 8.54% | 5.58% | 10.79% | 11.06% | 5.36% | 15.59% |
Return on Capital Employed (ROCE) | - | 6.20% | 11.40% | 14.00% | 7.10% | 19.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.05% | 5.12% | 4.50% | 4.47% | 2.95% | 5.81% |
FCF Yield | -1.15% | -2.85% | -3.51% | 0.09% | -9.66% | -6.04% |
Dividend Yield | 0.24% | 0.59% | 0.42% | - | - | - |
Payout Ratio | - | 11.44% | - | - | - | - |
Buyback Yield / Dilution | -1.38% | -2.46% | -4.71% | -1.79% | 3.39% | -15.24% |
Total Shareholder Return | -1.14% | -1.87% | -4.29% | -1.79% | 3.39% | -15.24% |